Thing is RAD have very little cash reserve $2million or so CHM has $15 Million with market caps at around $20 Million.
Seems absurd that CHM suite of assets is worth that MC
if sentiment in biotech was as it was 3 yrs ago we would see MC at 200M+
RAD might turn round on positive trial results but think they may need CR much sooner which was a huge flop so I’m wary to buy there til that is completed.
